Agilent Technologies, Inc. A
- Market cap
- $49.0B
- P/E
- 33.9×
Follow A
Agilent Technologies, Inc. (A) Price to free cash flow
As of 25 September 2026, Agilent Technologies, Inc. (A) trades at a price to free cash flow of 38.4×. Over the past ten years it has ranged from 20.4× (October 2016) to 59.6× (May 2015); the current reading is higher than 83% of that period. That is above the Diagnostics & Research industry median of 34.0× and above the Healthcare sector median of 19.5×.
Price to free cash flow, daily
Annual
| Period | Price to free cash flow | Change |
|---|---|---|
| FY2025 | 36.0× | 30.58% |
| FY2024 | 27.6× | 33.51% |
| FY2023 | 20.7× | (49.16%) |
| FY2022 | 40.6× | 10.21% |
| FY2021 | 36.9× | (8.96%) |
| FY2020 | 40.5× | 47.45% |
| FY2019 | 27.5× | 20.31% |
| FY2018 | 22.8× | (25.69%) |
| FY2017 | 30.7× | 41.46% |
| FY2016 | 21.7× | (28.00%) |
Quarterly
| Period | Price to free cash flow | Change |
|---|---|---|
| Jul 2026 | 30.7× | 2.76% |
| Apr 2026 | 29.9× | (22.30%) |
| Jan 2026 | 38.5× | 6.91% |
| Oct 2025 | 36.0× | 20.41% |
| 43 more quarters | Free account |
Against its own ten years
Price to free cash flow against peers
| Company | Price to free cash flow |
|---|---|
| GH Guardant Health, Inc. compare | n/m |
| DGX Quest Diagnostics Incorporated compare | 19.4× |
| IQV IQVIA Holdings Inc. compare | 19.9× |
| IDXX IDEXX Laboratories, Inc. compare | 33.1× |
| MTD Mettler-Toledo International, Inc. compare | 35.2× |
| A Agilent Technologies, Inc. | 38.4× |
| ILMN Illumina, Inc. compare | 44.9× |
| WAT Waters Corporation compare | 116× |
| NTRA Natera, Inc. compare | 702× |
| Diagnostics & Research industry median | 34.0× |
| Healthcare sector median | 19.5× |
| Market median | 14.0× |
What Price to free cash flow is
Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.
Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))
More on A
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement